Denali Capital Acquisition Corp. (ticker: DECA)

DECA

Definitive Agreement

Longevity Biomedical, Inc

DECAU

First	2022-04-07	$10.03
Recent	2024-06-03	$6.81	32%

Denali Capital Acquisition Corp.

Sponsors: Denali Capital Global Investments US Tiger Securities

Underwriter: US Tiger Securities, EF Hutton, Tiger Brokers (NZ), Joseph Gunnar

Leadership: Jiandong Xu, Lei Huang, Huifeng Chang, Jim Mao, Kevin Vassily

Raised: $75M
CIK: 1913577
SPAC Ticker: DECAU
Merger: Longevity Biomedical, Inc
Focus: Technology, Consumer, Hospitality

Sign in for detailed analysis →

External link: SEC Filings